Financhill
Back

Pacira BioSciences Quote, Financials, Valuation and Earnings

Pacira BioSciences Price Quote

$19.89
+0.03 (+0.45%)
(Updated: December 14, 2024 at 5:46 AM ET)

Pacira BioSciences Key Stats

Sell
47
Pacira BioSciences (PCRX) is a Sell

Day range:
$18.73 - $19.91
52-week range:
$11.16 - $35.95
Dividend yield:
0%
P/E ratio:
22.25
P/S ratio:
1.55
P/B ratio:
1.22%

Volume:
605.3K
Avg. volume:
726K
1-year change:
-33.53%
Market cap:
$914.2M
Revenue:
$675M
EPS:
$-2.01

How Much Does Pacira BioSciences Make?

Is Pacira BioSciences Growing As A Company?

  • What Is Pacira BioSciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.03%
  • What Is Pacira BioSciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Pacira BioSciences Stock Price Performance

What Is Pacira BioSciences 52-Week High & Low?

Pacira BioSciences Price To Free Cash Flow

Is It Risky To Buy Pacira BioSciences?

  • How Much Debt Does Pacira BioSciences Have?
    Total long term debt quarterly is $587.4M
  • How Much Cash Does Pacira BioSciences Have?
    Cash and short term investments quarterly total is $453.8M
  • What Is Pacira BioSciences’s Book Value Per Share?
    Book value per share is 16.24

Is Pacira BioSciences Cash Flow Positive?

  • What Is PCRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $203.8M
  • What Is Pacira BioSciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $17.5M
  • What Is Pacira BioSciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$74.5M

Pacira BioSciences Return On Invested Capital

  • Is Management Doing A Good Job?
    PCRX return on invested capital is -6.51%
  • What Is Pacira BioSciences Return On Assets?
    ROA measures how assets are converting to revenues and is -5.77%
  • What Is PCRX Return On Equity?
    ROE is a measure of profitability and is -10.74%

Pacira BioSciences Earnings Date & Stock Price

Pacira BioSciences Competitors

  • Who Are Pacira BioSciences's Competitors?
    Below is a list of companies who compete with Pacira BioSciences or are related in some way:
    • Cyclo Therapeutics Inc (CYTH)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Pacira BioSciences Dividend Yield

Pacira BioSciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 12.07%
Revenue: 2.84% -0.55%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 4
Sell Recommendations: 1
Price Target: 18.13
Downside from Last Price: -8.74%

Major Shareholders

  • How many PCRX shares are owned by institutional investors?
    70.5M PCRX shares are owned by institutional investors
  • How many PCRX shares are owned by insiders?
    1.3M PCRX shares are owned by insiders